Get the app!
Back to Trades
Grant4

AMGEN INC

AMGN

Total Value
$0

Company Information

Company Name
AMGEN INC
Ticker Symbol
AMGN
CIK
0000318154

Insider Information

Role
EVP & CFO
Officer
Location
THOUSAND OAKS, CA

Filing Details

Filing Date
Mar 5, 2026
Transaction Date
Mar 3, 2026
Accession Number
0000318154-26-000017
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Mar 3, 2026Common Stock12,063Grant/Award

Footnotes

  1. (F1)These shares include 676 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.